Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly Populations

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-69
SponsorTongji Hospital

About this trial

The goal of this randomized controlled trial is to evaluate the effectiveness of wearable devices (Huawei smartwatches) in aiding the detection, and screening of major diseases (e.g., coronary artery disease, hypertension) in middle-aged and elderly populations aged 40-69 years with cardiovascular risk factors (e.g., smoking, diabetes, hypertension, dyslipidemia). The main questions it aims to answer are:

Does AI-assisted diagnosis using wearable device data improve the detection rate of coronary artery stenosis (CAD-RADS ≥3) compared to standard physician assessment without AI assistance?

Does the intervention reduce the incidence of coronary artery disease-related events (e.g., angina, myocardial infarction) within one year?

Researchers will compare the intervention group (AI model-assisted diagnosis based on Huawei smartwatch data) with the control group (standard assessment) to determine if the AI-aided smartwatch approach enhances diagnostic accuracy and clinical outcomes.

Participants will:

(Intervention group)Wear a Huawei smartwatch for 24 hours to collect physiological data (e.g., PPG signals, heart rate, motion).

Undergo baseline assessments, including medical history review, physical exams, and laboratory tests.

Receive a preliminary diagnosis from a general practitioner.

Complete a follow-up evaluation after one year to track cardiovascular events and other disease outcomes.

Undergo coronary CTA if suspected of coronary stenosis.

Eligibility criteria

Qualifiers

Aged more than equal to 40 years, less than 69 years.

Agree to receive coronary CTA if suspected to have coronary artery stenosis.

Voluntarily joined and signed the informed consent.

Disqualifiers

Previously diagnosed with CAD or considered moderate to severe coronary stenosis (CAD-RADS grade 3 or above: stenosis degree of 50% or above) through coronary CTA or coronary angiography examination.

Pregnant women or women planning to become pregnant within the next year.

During the onset of the disease and needs in-hospital treatment.

Tattoos or other substances that affect optical signals on the wrist.

Trial design

Treatments tested in this trial

  • Smartwatch + GP
  • GP only

Treatment groups

800 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Tongji Hospital

Lead sponsor

Geriatric Hospital of Nanjing Medical University

Collaborator

Yangzhou University

Collaborator

Shanghai Health and Medical Center

Collaborator

Weifang Hospital of Traditional Chinese Medicine

Collaborator

CR & WSICO general hospital

Collaborator

Xunxian People's Hospital

Collaborator